In Vitro Anticancer Activity of Phlorofucofuroeckol A via Upregulation of Activating Transcription Factor 3 against Human Colorectal Cancer Cells

Mar Drugs. 2016 Mar 29;14(4):69. doi: 10.3390/md14040069.

Abstract

Phlorofucofuroeckol A (PFF-A), one of the phlorotannins found in brown algae, has been reported to exert anti-cancer property. However, the molecular mechanism for the anti-cancer effect of PFF-A has not been known. Activating transcription factor 3 (ATF3) has been reported to be associated with apoptosis in colorectal cancer. The present study was performed to investigate the molecular mechanism by which PFF-A stimulates ATF3 expression and apoptosis in human colorectal cancer cells. PFF-A decreased cell viability through apoptosis of human colorectal cancer cells. PFF-A increased ATF3 expression through regulating transcriptional activity. The responsible cis-element for ATF3 transcriptional activation by PFF-A was cAMP response element binding protein (CREB), located between positions -147 and -85 of the ATF3 promoter. Inhibition of p38, c-Jun N-terminal kinases (JNK), glycogen synthase kinase (GSK) 3β, and IκB kinase (IKK)-α blocked PFF-A-mediated ATF3 expression. ATF3 knockdown by ATF3 siRNA attenuated the cleavage of poly (ADP-ribose) polymerase (PARP) by PFF-A, while ATF3 overexpression increased PFF-A-mediated cleaved PARP. These results suggest that PFF-A may exert anti-cancer property through inducing apoptosis via the ATF3-mediated pathway in human colorectal cancer cells.

Keywords: Eisenia bicyclis; activating transcription factor 3; apoptosis; human colorectal cancer; phlorofucofuroeckol A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 3 / genetics*
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Benzofurans / pharmacology*
  • CREB-Binding Protein / genetics
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Dioxins / pharmacology*
  • Glycogen Synthase Kinase 3 beta / genetics
  • HCT116 Cells
  • HT29 Cells
  • Humans
  • I-kappa B Kinase / genetics
  • JNK Mitogen-Activated Protein Kinases / genetics
  • Promoter Regions, Genetic / drug effects
  • Signal Transduction / drug effects
  • Transcription, Genetic / drug effects
  • Transcriptional Activation / drug effects
  • Up-Regulation / drug effects*

Substances

  • ATF3 protein, human
  • Activating Transcription Factor 3
  • Antineoplastic Agents
  • Benzofurans
  • Dioxins
  • phlorofucofuroeckol A
  • CREB-Binding Protein
  • Glycogen Synthase Kinase 3 beta
  • I-kappa B Kinase
  • JNK Mitogen-Activated Protein Kinases